The group suing Pfizer over a fellowship program created to grow the number of Black, Latino and Native American people in leadership positions at the company has lost their appeal.
The lawsuit was initially defeated in a U.S. district court in Manhattan. On Wednesday, a U.S. appeals court upheld the decision to dismiss the lawsuit, Reuters reports.
According to Bloomberg Law, the group that brought the lawsuit against Pfizer is called Do No Harm. They claimed Pfizer’s program was discriminatory because only Black people, Latinos and Native Americans could apply.
The appeals court said that the group lacked standing because “it did not identify by name a single member injured by Pfizer’s alleged discrimination,” Reuters reports.
In a statement, Pfizer reaffirmed that the company is an “equal opportunity employer and is proud of its commitment to diversity, equity and inclusion.”
AsAmNews is published by the non-profit, Asian American Media Inc.
We are supported through donations and such charitable organizations as the Robert Wood Johnson Foundation. Donations to Asian American Media Inc and AsAmNews are tax-deductible. It’s never too late to give.
Please also follow us on Instagram, TikTok, Facebook, YouTube and X.